SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The December 2022 quarter revenue stood at Rs. 119.05 millions, up 10.79% as compared to Rs. 107.46 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2022 is Rs. -0.04 millions as compared to Net Profit of Rs. 4.78 millions of corresponding quarter ended December 2021The Operating Profit of the company witnessed a decrease to 2.04 millions from 7.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 119.05 107.46 10.79 338.94 308.09 10.01 401.34 251.78 59.40
Other Income 0.84 0.70 20.00 2.53 2.13 18.78 3.06 8.02 -61.85
PBIDT 2.04 7.12 -71.35 -17.14 30.23 -156.70 14.24 -19.66 -172.43
Interest 1.39 1.03 34.95 5.55 2.55 117.65 4.01 3.89 3.08
PBDT 0.65 6.09 -89.33 -22.69 27.68 -181.97 10.23 -23.55 -143.44
Depreciation 0.69 0.56 23.21 2.07 1.60 29.37 2.76 1.76 56.82
PBT -0.04 5.53 -100.72 -24.76 26.08 -194.94 7.47 -25.31 -129.51
TAX 0.00 0.75 0.00 0.00 0.75 0.00 -1.26 -0.11 1045.45
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -0.11 1045.45
PAT -0.04 4.78 -100.84 -24.76 25.33 -197.75 8.73 -25.20 -134.64
Equity 74.20 74.20 0.00 74.20 74.20 0.00 74.20 74.20 0.00
PBIDTM(%) 1.71 6.63 -74.14 -5.06 9.81 -151.54 3.55 -7.81 -145.44

Guj. Terce Lab Share Price

40.05 6.15 (18.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×